Programme 04
Cost Optimisation — value, safely realised.
Prescribing efficiency, deprescribing where appropriate, and formulary-aligned switches — savings reported per PCN and per ICB priority.
What we target
Where the savings come from.
- Therapeutic switches aligned to local formulary
- Generic vs brand opportunities
- Wastage and over-ordering reduction
- Polypharmacy deprescribing
- Specialist drug reviews
- Repeat prescribing quantity and synchronisation
How we work
Savings, safely realised.
- ICB and PCN priorities mapped before any switch is proposed
- Patient-by-patient clinical review — never a blanket switch
- GP sign-off on every change
- Patient comms drafted and sent by BCS, not added to GP workload
- Post-switch monitoring built into the BCS Impact Dashboard
Typical first-year outcomes
Measured monthly and reported to your PCN.
£6–£12
Saved per patient on caseload
100%
Switches with GP sign-off
↓
Medicines wastage
0
Patient-safety incidents from switches
DES 26/27 alignment
Tied to the Network Contract DES.
Cost optimisation work is fully aligned to the medicines optimisation requirements of the Network Contract DES, IIF prescribing indicators, and local ICB formulary positions. Every saving is auditable and CQC-ready.
Related BCS work.
Repeat Prescribing Optimisation
The day-to-day repeat process that prevents waste at source.
Read about repeat prescribing optimisation
Polypharmacy & Frailty Programme
Structured deprescribing for 65+ on 8+ medications.
Read about polypharmacy & frailty programme
Impact Dashboard
Where savings, switches and safety metrics are reported every month.
Read about impact dashboard
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.
